MEF2C and gastric cancer: A study constructed a decision tree using mutations in PIK3CA, MEF2C, SLC11A1, and KIF15 to divided patient sub-cohorts with elevated PD-L1 expression, which contribute to identify the novel prognostic biomarkers of Gastric Cancer (51).